3 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18488169 | BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment | HOWELL, THEODORE R | 1628 | Non-Final OA | Oct 17, 2023 |
| 18487254 | Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide | WILLIS, DOUGLAS M | 1624 | Final Rejection | Oct 16, 2023 |
| 18001740 | ACALABRUTINIB MALEATE DOSAGE FORMS | HAVLIN, ROBERT H | 1626 | Final Rejection | Dec 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial